应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
EVMN Evommune
休市中 12-12 16:00:00 EST
18.01
-1.68
-8.53%
盘后
18.01
+0.00
0.00%
19:55 EST
最高
20.85
最低
17.20
成交量
12.38万
今开
19.27
昨收
19.69
日振幅
18.53%
总市值
5.68亿
流通市值
1.69亿
总股本
3,152万
成交额
225.67万
换手率
1.32%
流通股本
940.00万
市净率
--
ROE
--
每股收益
0.00
52周最高
--
52周最低
--
市盈率
--
股息
--
股息收益率
--
ROA
--
分时
五日
日K
周K
月K
数据加载中...
北京优虎网络科技有限公司
资讯
新帖
简况
Evommune首次公开募股定价为每股16美元,发行937.5万股
投资观察 · 11-20
Evommune首次公开募股定价为每股16美元,发行937.5万股
美股异动 | 生物医药公司Evommune(EVMN.US)登陆美股市场 股价涨超15%
智通财经 · 11-07
美股异动 | 生物医药公司Evommune(EVMN.US)登陆美股市场 股价涨超15%
慢性炎症性疾病生物科技公司Evommune(EVMN.US)IPO定价15-17美元/股 拟筹资1.5亿美元
智通财经 · 10-20
慢性炎症性疾病生物科技公司Evommune(EVMN.US)IPO定价15-17美元/股 拟筹资1.5亿美元
加载更多
公司概况
公司名称:
Evommune
所属市场:
NYSE
上市日期:
--
主营业务:
Evommune, Inc.是一家于2020年4月在特拉华州注册成立的公司,总部位于加利福尼亚州的帕洛阿尔托。该公司是一家临床阶段的生物技术公司,专注于针对慢性炎症疾病主要致病因素的创新治疗方案开发。其初步临床开发项目集中在慢性自发性荨麻疹、特应性皮炎和溃疡性结肠炎上。
发行价格:
--
{"stockData":{"symbol":"EVMN","market":"US","secType":"STK","nameCN":"Evommune","latestPrice":18.01,"timestamp":1765573200000,"preClose":19.69,"halted":0,"volume":123802,"hourTrading":{"tag":"盘后","latestPrice":18.01,"preClose":18.01,"latestTime":"19:55 EST","volume":381,"amount":6902.52,"timestamp":1765587320898},"delay":0,"floatShares":9400000,"shares":31524100,"eps":-5.148378,"marketStatus":"休市中","change":-1.68,"latestTime":"12-12 16:00:00 EST","open":19.27,"high":20.85,"low":17.2024,"amount":2256708.04373,"amplitude":0.185251,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":-5.148378,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1765789200000},"marketStatusCode":7,"adr":0,"listingDate":1762405200000,"exchange":"NYSE","adjPreClose":19.69,"postHourTrading":{"tag":"盘后","latestPrice":18.01,"preClose":18.01,"latestTime":"19:55 EST","volume":381,"amount":6902.52,"timestamp":1765587320898},"volumeRatio":0.712419128157913},"requestUrl":"/m/hq/s/EVMN","defaultTab":"news","newsList":[{"id":"1101351099","title":"Evommune首次公开募股定价为每股16美元,发行937.5万股","url":"https://stock-news.laohu8.com/highlight/detail?id=1101351099","media":"投资观察","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1101351099?lang=zh_cn&edition=full","pubTime":"2025-11-20 00:46","pubTimestamp":1763570777,"startTime":"0","endTime":"0","summary":"11月5日 - Evommune Inc 公告:*Evommune宣布首次公开募股定价* Evommune Inc - 首次公开募股定价为每股16美元,共发行937.5万股","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EVMN"],"gpt_icon":0},{"id":"2581015296","title":"美股异动 | 生物医药公司Evommune(EVMN.US)登陆美股市场 股价涨超15%","url":"https://stock-news.laohu8.com/highlight/detail?id=2581015296","media":"智通财经","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2581015296?lang=zh_cn&edition=full","pubTime":"2025-11-07 00:00","pubTimestamp":1762444800,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,Evommune(EVMN.US)登陆美股市场,截至发稿,该股涨超15%,报18.38美元,IPO价格为16美元。Evommune 是一家临床阶段的生物医药公司,其使命是通过创新疗法,治疗 “免疫介导的慢性炎症性疾病”。这类疾病包括慢性荨麻疹、特应性皮炎、其他与肥大细胞/炎症相关的病症。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1366323.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["399441","161726","EVMN"],"gpt_icon":0},{"id":"2576361788","title":"慢性炎症性疾病生物科技公司Evommune(EVMN.US)IPO定价15-17美元/股 拟筹资1.5亿美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2576361788","media":"智通财经","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2576361788?lang=zh_cn&edition=full","pubTime":"2025-10-20 15:54","pubTimestamp":1760946879,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,专注研发慢性炎症性疾病疗法的二期临床阶段生物科技公司Evommune于上周五公布了其首次公开募股的发行条款。公司计划通过发行940万股股票筹集1.5亿美元,发行价区间设定为15至17美元。若按发行价区间中值计算,Evommune的市值将达到5.43亿美元。该药物已启动2b期临床试验,预计于2026年下半年公布结果。由于美国政府持续停摆,Evommune未依赖美国证券交易委员会宣布其注册声明生效。公司预计于2025年11月3日当周确定最终发行价。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1357011.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["EVMN","159837"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.evommune.com","stockEarnings":[{"period":"1week","weight":-0.1776},{"period":"1month","weight":-0.0774},{"period":"3month","weight":0.1256},{"period":"ytd","weight":0.1256}],"compareEarnings":[{"period":"1week","weight":-0.0057},{"period":"1month","weight":-0.0024},{"period":"3month","weight":0.037},{"period":"6month","weight":0.142},{"period":"1year","weight":0.1281},{"period":"ytd","weight":0.1633}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Evommune, Inc.是一家于2020年4月在特拉华州注册成立的公司,总部位于加利福尼亚州的帕洛阿尔托。该公司是一家临床阶段的生物技术公司,专注于针对慢性炎症疾病主要致病因素的创新治疗方案开发。其初步临床开发项目集中在慢性自发性荨麻疹、特应性皮炎和溃疡性结肠炎上。","exchange":"NYSE","name":"Evommune","nameEN":"Evommune"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.11","shortVersion":"4.35.11","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Evommune(EVMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Evommune(EVMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Evommune,EVMN,Evommune股票,Evommune股票老虎,Evommune股票老虎国际,Evommune行情,Evommune股票行情,Evommune股价,Evommune股市,Evommune股票价格,Evommune股票交易,Evommune股票购买,Evommune股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Evommune(EVMN)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Evommune(EVMN)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}